More About Epidemiology & Biostatistics Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Allison Lipitz-Snyderman , PhD

Assistant Attending Outcomes Research Scientist

Allison Lipitz-Snyderman

Office Phone

646-888-8215

Education

Johns Hopkins University

Dr. Allison Lipitz-Snyderman is a health services researcher focused on quality assessment and improvement in cancer care. Her research falls into three general areas: assessment of variation in practice and outcomes, examination of harm due to medical care, and evaluation of quality improvement activities. Dr. Lipitz-Snyderman received funding from the National Institute for Health Care Management Foundation to assess the extent of physician-driven variation in the use of services that tend to be overused. She is currently building on this work to examine hospital-level variation in outcomes of cancer care. Dr. Lipitz-Snyderman has worked to assess the burden of potentially preventable harm that occurs during cancer treatment in both inpatient and outpatient settings. She led a study to develop an oncology-specific ‘trigger tool’ to detect harm from medical records for patients with cancer over the care continuum, funded by the United Hospital Fund. Dr. Lipitz-Snyderman also led an evaluation of a multifaceted intervention, the Michigan Keystone ICU Project, aimed to reduce device-related bloodstream infections across the state of Michigan, along the outcomes of mortality and length of stay using population-based data. Dr. Lipitz-Snyderman is a member of the MSK Center for Health Policy and Outcomes and is Co-chair of the MSK Cancer Alliance Quality, Value, and Outcomes Committee.

Publications

Selected peer-reviewed publications:


  1. Lipitz-Snyderman A, Steinwachs D, Needham DM, Colantuoni E, Morlock LL, Pronovost PJ. Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis. BMJ. 2011 Jan 28;342:d219. PMID: 21282262. PMCID: 3031651.

  2. Lipitz-Snyderman A, Sepkowitz KA, Elkin EB, Pinheiro LC, Sima CS, Son CH, Atoria CL, Bach PB. Long-Term Central Venous Catheter Use and Risk of Infection in Older Adults With Cancer. J Clin Oncol. 2014 Aug 1;32(22):2351-6. PMID: 24982458. PMCID: PMC4105488.

  3. Lipitz-Snyderman A, Sima CS, Atoria CL, Elkin EB, Anderson C, Blinder V, Tsai CJ, Panageas KS, Bach PB. Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer. JAMA Intern Med. 2016 Oct 1;176(10):1541-1548. PMID: 27533635. PMCID: PMC5363077.

  4. Lipitz-Snyderman A, Korenstein D. Reducing Overuse-Is Patient Safety the Answer? [invited editorial] JAMA. 2017 Feb 28;317(8):810-811. PMID: 28245304.

  5. Lipitz-Snyderman A, Pfister D, Classen DC, Killen AK, Atoria CL, Epstein A, Anderson C, Fortier E, & Weingart S. Preventable adverse events in cancer care: Measuring risk and harm across the continuum. Cancer. (in press)

For a complete list of publications:

https://www.ncbi.nlm.nih.gov/sites/myncbi/allison.lipitz snyderman.1/bibliography/40887022/public/?sort=date&direction=ascending